A bioengineered model incorporating a synthetic extracellular matrix recapitulates the lymphoid tumour microenvironment, making it a valuable tool for drug testing and designing personalized therapies.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Hanahan, D. & Weinberg, R. A. Cell 144, 646–674 (2011).
Whiteside, T. L. Oncogene 27, 5904–5912 (2008).
Quail, D. F. & Joyce, J. A. Nat. Med. 19, 1423–1437 (2013).
Weiss, F., Lauffenburger, D. & Friedl, P. Nat. Rev. Cancer 22, 157–173 (2022).
Shah, B. S. et al. Nat. Mater. https://doi.org/10.1038/s41563-023-01495-3 (2023).
Schmitz, R. et al. N. Engl. J. Med. 378, 1396–1407 (2018).
Chapuy, B. et al. Nat. Med. 24, 679–690 (2018).
Lu, Y., Aimetti, A. A., Langer, R. & Gu, Z. Nat. Rev. Mater. 2, 16075 (2016).
Gu, L. & Mooney, D. J. Nat. Rev. Cancer 16, 56–66 (2016).
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gaharwar, A.K., Singh, I. A synthetic tumour microenvironment. Nat. Mater. (2023). https://doi.org/10.1038/s41563-023-01511-6